Switch to:
More From Other Websites
POZEN INC /NC Files SEC form 10-K, Annual Report Mar 11 2015
POZN: Yosprala Remains High Priority As We Wait For API Supplier To Rectify Deficiencies… Mar 10 2015
What We're Trading Mar 09 2015
POZEN Reports Fourth Quarter and Year End 2014 Results Mar 09 2015
Pozen posts 4Q profit Mar 09 2015
Pozen posts 4Q profit Mar 09 2015
POZEN Reports Fourth Quarter and Year End 2014 Results Mar 09 2015
POZEN Announces March 9th Webcast of Fourth Quarter and Year End 2014 Results Mar 04 2015
POZEN Announces March 9th Webcast of Fourth Quarter and Year End 2014 Results Mar 04 2015
Coverage initiated on POZEN by Chardan Capital Markets Feb 18 2015
POZEN Announces Issuance of VIMOVO® Related Patent by the United States Patent and Trademark Office Feb 04 2015
POZEN Announces Issuance of VIMOVO® Related Patent by the United States Patent and Trademark Office Feb 04 2015
POZEN INC /NC Files SEC form 8-K, Change in Directors or Principal Officers Jan 05 2015
POZEN INC /NC Files SEC form 8-K, Termination of a Material Definitive Agreement Dec 29 2014
Equity markets surge...so many stories – where to begin? Dec 17 2014
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pozen, Inc. -... Dec 17 2014
POZEN Inc. Update on 2nd CRL from the FDA for YOSPRALA Call scheduled for 8:30 am ET today Dec 17 2014
POZEN INC /NC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 17 2014
POZEN’s YOSPRALA™ Receives Complete Response Letter from The FDA Dec 17 2014
POZEN’s YOSPRALA™ Receives Complete Response Letter from The FDA Dec 17 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK